Equities research analysts at Stifel Nicolaus started coverage on shares of Global Medical REIT (NYSE:GMRE) in a report released on Monday, The Fly reports. The brokerage set a “buy” rating on the stock.

Other analysts also recently issued reports about the company. B. Riley set a $11.00 price target on Global Medical REIT and gave the stock a “buy” rating in a research report on Friday, March 8th. Boenning Scattergood restated a “buy” rating on shares of Global Medical REIT in a research report on Thursday, March 7th. Zacks Investment Research upgraded Global Medical REIT from a “hold” rating to a “buy” rating and set a $11.00 price target for the company in a research report on Wednesday, February 13th. Finally, Janney Montgomery Scott downgraded Global Medical REIT from a “buy” rating to a “neutral” rating and set a $9.03 target price for the company. in a research report on Wednesday, December 19th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $10.61.

Shares of GMRE opened at $9.74 on Monday. The firm has a market capitalization of $260.07 million, a P/E ratio of 12.49, a P/E/G ratio of 1.32 and a beta of 0.61. Global Medical REIT has a 52-week low of $7.14 and a 52-week high of $11.02. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 1.25.

Global Medical REIT (NYSE:GMRE) last issued its quarterly earnings results on Thursday, March 7th. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.21 by $0.10. The company had revenue of $14.38 million during the quarter, compared to the consensus estimate of $14.46 million. Global Medical REIT had a return on equity of 6.29% and a net margin of 22.62%. On average, sell-side analysts anticipate that Global Medical REIT will post 0.83 earnings per share for the current fiscal year.

In other news, Director Roscoe M. Moore, Jr. sold 5,945 shares of Global Medical REIT stock in a transaction on Monday, March 18th. The stock was sold at an average price of $9.75, for a total transaction of $57,963.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 13.00% of the stock is currently owned by company insiders.

Large investors have recently added to or reduced their stakes in the company. State of Alaska Department of Revenue lifted its position in shares of Global Medical REIT by 19.9% during the first quarter. State of Alaska Department of Revenue now owns 7,412 shares of the company’s stock worth $72,000 after purchasing an additional 1,229 shares during the last quarter. D. E. Shaw & Co. Inc. purchased a new position in shares of Global Medical REIT during the fourth quarter valued at $89,000. Bank of America Corp DE increased its stake in shares of Global Medical REIT by 113.3% during the fourth quarter. Bank of America Corp DE now owns 10,296 shares of the company’s stock valued at $92,000 after buying an additional 5,470 shares during the period. Schnieders Capital Management LLC purchased a new position in shares of Global Medical REIT during the fourth quarter valued at $116,000. Finally, Squarepoint Ops LLC purchased a new position in shares of Global Medical REIT during the fourth quarter valued at $118,000. Institutional investors and hedge funds own 41.76% of the company’s stock.

Global Medical REIT Company Profile

Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Featured Article: Trading Options- What is a Strangle?

The Fly

Analyst Recommendations for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.